Vycor Medical annual return on equity
2011
2015
2016
2017
2021
Vycor Medical Return on Equity (ROE) Growth & History (VYCO)
Vycor Medical's return on equity was −210.52% for fiscal 2021.
View full Vycor Medical company overviewVycor Medical annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-12-31 | −210.52% | — |
| 2017 | 2017-12-31 | −5,370.68% | −5075.44 pp |
| 2016 | 2016-12-31 | −295.24% | −192.00 pp |
| 2015 | 2015-12-31 | −103.24% | — |
| 2011 | 2011-12-31 | −991.36% | — |
Vycor Medical quarterly return on equity
Q2.11
Q3.11
Q4.11
Q1.12
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q4.21
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2021 | 2021-12-31 | −276.93% | — |
| Q4 2017 | 2017-12-31 | −152.08% | +109.50 pp |
| Q3 2017 | 2017-09-30 | −67.68% | −4.88 pp |
| Q2 2017 | 2017-06-30 | −44.95% | −5.06 pp |
| Q1 2017 | 2017-03-31 | −86.36% | −34.09 pp |
| Q4 2016 | 2016-12-31 | −261.58% | −229.17 pp |
| Q3 2016 | 2016-09-30 | −62.80% | −33.68 pp |
| Q2 2016 | 2016-06-30 | −39.90% | −20.44 pp |
| Q1 2016 | 2016-03-31 | −52.27% | −24.66 pp |
| Q4 2015 | 2015-12-31 | −32.41% | −12.21 pp |
| Q3 2015 | 2015-09-30 | −29.13% | +25.58 pp |
| Q2 2015 | 2015-06-30 | −19.46% | +186.83 pp |
| Q1 2015 | 2015-03-31 | −27.61% | — |
| Q4 2014 | 2014-12-31 | −20.20% | — |
| Q3 2014 | 2014-09-30 | −54.71% | — |
| Q2 2014 | 2014-06-30 | −206.28% | — |
| Q1 2012 | 2012-03-31 | −124.48% | — |
| Q4 2011 | 2011-12-31 | −65.62% | — |
| Q3 2011 | 2011-09-30 | −62.37% | — |
| Q2 2011 | 2011-06-30 | −180.60% | — |
Vycor Medical return on equity trends
Over the last five fiscal years, Vycor Medical's return on equity increased from −295.24% to −210.52%, a change of +84.72 percentage points. The latest reported quarter, Q4 2021, shows −276.93%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vycor Medical source filings ↗